Clinical Trials on Crow's Feet Lines

Total 2746 results

Allergan

Completed

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Lateral Canthal Lines | Crow's Feet Lines

Korea, Republic of
Allergan

Completed

BOTOX® in the Treatment of Crow's Feet Lines in China

Lateral Canthal Lines | Crow's Feet Lines

China
Samyang Biopharmaceuticals Corporation

Not yet recruiting

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

Crow's Feet Lines
Daewoong Pharmaceutical Co. LTD.

Unknown

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

Glabellar Lines | Crow's Feet Lines
Hugel

Completed

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Crow's Feet Lines

Korea, Republic of
Huons Co., Ltd.

Unknown

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

Crow's Feet Lines

Korea, Republic of
Medy-Tox

Completed

MEDITOXIN® in Treatment of Crow's Feet Line

Crow's Feet Lines

Korea, Republic of
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-208

Lateral Canthal Lines | Crow's Feet

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines

Lateral Canthal Lines | Crow's Feet

United States
Anterios Inc.

Completed

Dose Finding Study In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Anterios Inc.

Completed

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Lateral Canthal Lines | Crow's Feet

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Lateral Canthal Lines | Crow's Feet

United States
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

Crow's Feet Lines | Lateral Canthus Rhytides

Belgium, Canada, United States, United Kingdom
Allergan

Completed

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Crow's Feet Lines | Lateral Canthus Rhytides

Japan
Daewoong Pharmaceutical Co. LTD.

Unknown

Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

Crows Feet Lines

Korea, Republic of
Eirion Therapeutics Inc.

Active, not recruiting

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Crow's Feet | Lateral Canthal Lines, LCL

United States
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Crow's Feet | Lateral Canthal Lines, LCL

United States
Anterios Inc.

Completed

Clinical Trial to Evaluate ANT-1401 in Crow's Feet

Lateral Canthal Lines | Crows Feet

United States
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Glabellar Lines | Crow's Feet Lines | Facial Rhytides

Germany, Canada, United States, France
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Glabellar Lines | Crow's Feet Lines | Facial Rhytides

Germany, Canada, United States, France
DEXLEVO

Completed

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet (dermal filler)

Crow's Feet Lines

Korea, Republic of
Allergan

Completed

BOTOX® in the Treatment of Upper Facial Lines in Japan

Glabellar Lines | Frown Lines | Crow's Feet Lines | Upper Facial Rhytides

Japan
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Allergan

Completed

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Glabellar Lines | Nasolabial Fold | Crow's Feet Lines | Facial Rhytides

United States
S.Biomedics Co., Ltd.
Dt&Sanomedics

Recruiting

A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet

Crow's Feet

Korea, Republic of
Teoxane SA

Completed

TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

Crow's Feet Wrinkles

Switzerland
Humedix Co., Ltd.

Recruiting

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

Crows Feet

Korea, Republic of
Dongkook Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of DKB-119 in Patients in Crow's Feet

Crow's Feet

Korea, Republic of
Galderma R&D

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Glabellar Frown Lines | Canthal Lines

United States
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada, United Kingdom
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device

Glabellar Frown Lines | Frown Lines

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device

Glabellar Frown Lines | Frown Lines

United States
Galderma R&D

Completed

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines (READY-4)

Lateral Canthal Lines | Glabellar Lines

United States, Puerto Rico
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines (ULTRA I)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)

United States, Canada
Merz North America, Inc.

Terminated

Longitudinal Evaluation and Real-world Evidence of NT201

Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

United States
Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination (READY-3)

Glabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)

United States, Canada
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. (ULTRA II)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Germany
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Glabellar Lines

Korea, Republic of
Allergan

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Glabellar Lines

United States, Canada
AbbVie

Active, not recruiting

A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants

Neck Lines

China
AbbVie

Active, not recruiting

A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Change in Neck Appearance in Adult Participants

Neck Lines

United States
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines

Glabellar Lines

United States, Belgium, Russian Federation

Clinical Trials on Crow's Feet Lines

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations